NEW YORK STATE COMMON RETIREMENT FUND - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 249 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.1%.

Quarter-by-quarter ownership
NEW YORK STATE COMMON RETIREMENT FUND ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$4,866
+25.1%
233,509
+43.8%
0.01%
+40.0%
Q2 2023$3,889
+227.4%
162,368
+157.2%
0.01%
+150.0%
Q1 2023$1,188
-13.0%
63,131
-26.4%
0.00%0.0%
Q4 2022$1,365
-99.9%
85,735
-0.1%
0.00%0.0%
Q3 2022$1,403,000
+25.7%
85,779
+8.3%
0.00%
+100.0%
Q2 2022$1,116,000
-46.6%
79,233
-8.2%
0.00%
-50.0%
Q1 2022$2,090,000
+3.9%
86,287
+0.1%
0.00%0.0%
Q4 2021$2,012,000
+40.1%
86,210
-0.3%
0.00%0.0%
Q3 2021$1,436,000
-42.1%
86,432
-15.0%
0.00%
-33.3%
Q2 2021$2,480,000
-20.8%
101,700
-16.2%
0.00%0.0%
Q1 2021$3,130,000
-59.1%
121,300
-15.4%
0.00%
-66.7%
Q4 2020$7,661,000
+16.1%
143,300
-10.4%
0.01%
+12.5%
Q3 2020$6,596,000
-24.7%
159,900
-11.5%
0.01%
-27.3%
Q2 2020$8,755,000
+86.9%
180,630
+62.9%
0.01%
+57.1%
Q1 2020$4,684,000
-10.8%
110,865
-9.7%
0.01%
+16.7%
Q4 2019$5,253,000
+14.7%
122,780
-3.5%
0.01%0.0%
Q3 2019$4,580,000
+58.8%
127,250
+17.9%
0.01%
+50.0%
Q2 2019$2,884,000
-8.6%
107,900
-8.1%
0.00%0.0%
Q1 2019$3,154,000
+96.3%
117,470
+18.2%
0.00%
+100.0%
Q4 2018$1,607,000
-29.3%
99,400
-9.2%
0.00%
-33.3%
Q3 2018$2,273,000
+35.9%
109,5000.0%0.00%
+50.0%
Q2 2018$1,672,000
-64.8%
109,500
-48.2%
0.00%
-66.7%
Q1 2018$4,748,000
-24.1%
211,300
+1.7%
0.01%
-25.0%
Q4 2017$6,257,000
-22.7%
207,800
-3.3%
0.01%
-20.0%
Q3 2017$8,092,000
+39.3%
214,800
+3.1%
0.01%
+25.0%
Q2 2017$5,809,000
-18.9%
208,300
-0.0%
0.01%
-20.0%
Q1 2017$7,161,000
+24.3%
208,301
+4.3%
0.01%
+25.0%
Q4 2016$5,762,000
-8.3%
199,800
+1.2%
0.01%
-11.1%
Q3 2016$6,281,000
+0.2%
197,469
+2.2%
0.01%0.0%
Q2 2016$6,271,000
+111.8%
193,179
+82.4%
0.01%
+80.0%
Q1 2016$2,961,000
-12.6%
105,885
+11.4%
0.01%0.0%
Q4 2015$3,387,000
+22.5%
95,020
+13.6%
0.01%
+25.0%
Q3 2015$2,765,000
-45.1%
83,620
-30.4%
0.00%
-42.9%
Q2 2015$5,032,000
+453.6%
120,162
+330.8%
0.01%
+600.0%
Q1 2015$909,000
-15.9%
27,893
-18.1%
0.00%
-50.0%
Q4 2014$1,081,00034,0600.00%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Sio Capital Management, LLC 563,200$16,243,0009.48%
Avoro Capital Advisors LLC 1,486,460$42,870,0008.66%
Baker Brothers Advisors 25,819,768$744,642,0007.30%
SECTORAL ASSET MANAGEMENT INC 1,176,543$33,932,0003.76%
HARVEY CAPITAL MANAGEMENT INC 251,825$7,262,0003.38%
ACUTA CAPITAL PARTNERS, LLC 300,000$8,652,0003.22%
Palo Alto Investors LP 1,532,030$44,184,0002.52%
Ghost Tree Capital, LLC 350,000$10,094,0002.43%
EMORY UNIVERSITY 76,121$2,195,0002.16%
WEATHERBIE CAPITAL, LLC 576,784$16,634,0002.09%
View complete list of ACADIA PHARMACEUTICALS INC shareholders